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Abstract: The origin and fate of renal myofibroblasts is not clear after acute kidney injury (AKI). Here,
we demonstrate that myofibroblasts were activated from quiescent pericytes (qPericytes) and the cell
numbers increased after ischemia/reperfusion injury-induced AKI (IRI-AKI). Myofibroblasts underwent
apoptosis during renal recovery but one-fifth of them survived in the recovered kidneys on day 28 after
IRI-AKI and their cell numbers increased again after day 56. Microarray data showed the distinctive
gene expression patterns of qPericytes, activated pericytes (aPericytes, myofibroblasts), and inactivated
pericytes (iPericytes) isolated from kidneys before, on day 7, and on day 28 after IRI-AKI. Hypermethy-
lation of the Acta2 repressor Ybx2 during IRI-AKI resulted in epigenetic modification of iPericytes to
promote the transition to chronic kidney disease (CKD) and aggravated fibrogenesis induced by a second
AKI induced by adenine. Mechanistically, transforming growth factor-฀1 decreased the binding of YBX2
to the promoter of Acta2 and induced Ybx2 hypermethylation, thereby increasing ฀-smooth muscle actin
expression in aPericytes. Demethylation by 5-azacytidine recovered the microvascular stabilizing function
of aPericytes, reversed the profibrotic property of iPericytes, prevented AKI-CKD transition, and attenu-
ated fibrogenesis induced by a second adenine-AKI. In conclusion, intervention to erase hypermethylation
of pericytes after AKI provides a strategy to stop the transition to CKD.
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Introduction
The conventional wisdom that survivors with full function-
al recovery from acute kidney injury (AKI) tend to have a good 
prognosis appears to be flawed (1, 2). Ongoing renal pathophysio-
logical processes after AKI may continue for a duration between 
7 and 90 days or beyond, disease courses defined as acute kidney 
disease (AKD) and chronic kidney disease (CKD), respectively 
(3, 4). That is, AKI, AKD, and CKD form a continuum whereby 
the initial kidney injury leads to ongoing renal injury and even-
tually end-stage renal disease if no effective treatment is provid-
ed (1–3). The known pathogenic mechanisms of the AKI-CKD 
transition include maladaptive repair, cell cycle (G2/M) arrest 
of tubular epithelial cells, perpetuated fibroblast activation, 
microvascular rarefaction, chronic inflammation, and sustained 
renin-angiotensin system (RAS) activation after AKI (4–12). At 
present, the only potentially effective treatment to prevent CKD 
has been RAS blockade during AKD (4, 13, 14), suggesting a huge 
unmet medical need.
Kidney pericytes are cells of mesenchymal origin that express 
platelet-derived growth factor receptor-β (PDGFRβ+) and colla-
gen. Pericytes attach to capillaries that share a common basement 
membrane and form junctions with endothelial cells to support 
microvasculature, regulate blood flow, and produce erythropoi-
etin (EPO) (9, 15–21). Previous studies have shown that pericytes 
are the progenitor cells of scar-producing myofibroblasts in CKD 
with progressive fibrosis (15, 22–24). Myofibroblasts express a 
high level of α-smooth muscle actin (αSMA) and migrate away 
from endothelial cells, actively proliferate and produce excessive 
amounts of extracellular matrix (ECM), thereby leading to scar 
formation and kidney atrophy. Meanwhile, myofibroblasts lose 
the function of microvascular stabilization and EPO production 
(9, 17, 25). In AKI with functional recovery, however, the fate and 
role of pericytes are poorly understood.
Selective pericyte ablation leads to AKI with endothelial cell 
damage, capillary rarefaction, and tubular injury (18, 19). In the 
absence of pericytes, however, renal fibrosis is mild despite the 
occurrence of AKI, echoing the crucial role of pericytes as the 
progenitor cells of myofibroblasts in CKD. In contrast, selective 
tubular cell ablation causes transient activation, proliferation, 
and migration of pericytes to enclose the injured tubular epithe-
lium and promote tubular regeneration (26). In line with these 
findings, our previous study demonstrated the transient increase 
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Results
AKI induced a transient increase of renal myofibroblasts. We induced 
IRI-AKI in adult male C57BL/6 mice by right nephrectomy (Nx) 
at the age of 8 weeks followed by left renal IRI 2 weeks later (Sup-
plemental Figure 1A; supplemental material available online with 
this article; https://doi.org/10.1172/JCI135773DS1). Plasma levels 
of blood urea nitrogen (BUN) and creatinine increased and peak-
ed on day 2 after IRI-AKI and decreased to comparable levels of 
Nx control (Ctrl) mice on day 30 (Supplemental Figure 1, B and 
C). Interestingly, BUN, creatinine, and urine albumin-creatinine 
ratio (UACR) increased significantly from day 180 (Supplemental 
Figure 1, B–D). Fibrosis was demonstrated in kidneys on day 30 
after IRI-AKI and increased progressively thereafter (Supplemen-
tal Figure 1, E and F). Similar to our previous report (4), progres-
sive glomerulosclerosis was also noted. We thus used the IRI-AKI 
model to study the AKI-CKD transition.
Transgenic Col1a1-GFP reporter mice (Col1a1-GFPTg) express 
green fluorescent protein (GFP) in renal pericytes (15). The cell 
number of Col1a1-GFP+ pericytes expressing αSMA, a marker of 
activated pericytes or myofibroblasts, increased markedly after 
IRI-AKI (Figure 1, A and B). Although αSMA+Col1a1-GFP+ myofi-
broblasts decreased after day 14, the cell number on day 56 was 
still higher than that in Ctrl kidney (Figure 1, A and B), with more 
than 80% of Col1a1-GFP+ pericytes being αSMA+ myofibroblasts 
from day 2 to day 14 after IRI-AKI (Figure 1, A and C). By contrast, 
of αSMA+ myofibroblasts in the acute phase of AKI induced by 
ischemia/reperfusion injury (IRI) (4, 27). Residual focal fibrosis 
and myofibroblasts noted in functionally recovered kidneys on 
day 28 after AKI are pathological findings possibly linked to the 
subsequent CKD transition (4, 28). In a progressive renal fibrosis 
model induced by folic acid, Bechtel et al. demonstrated that the 
hypermethylation of Rasal1, which encodes an inhibitor of the Ras 
oncoprotein, leads to perpetuated activation of myofibroblasts 
and renal fibrosis (8). Our previous study also demonstrated that 
the hypermethylation of Epo promoter and enhancer in myofibro-
blasts results in decreased EPO production and anemia in CKD 
(17). Demethylation by 5-azacytidine (5-Aza) not only increased 
Epo expression but also decreased Acta2 expression, suggesting 
the potential effect of demethylation in the reversal of myofibro-
blasts to pericytes (17).
Since pericytes participate in tissue repair, microvascular 
stability, and become scar-producing myofibroblasts in CKD 
(7, 9, 15–24, 26), we are intrigued by the fate and role of peri-
cytes in AKI. Our findings demonstrated that the activation of 
pericytes to myofibroblasts in AKI is associated with the hyper-
methylation of Ybx2, a gene encoding a Y-box–binding protein 
for Acta2 repression. During AKD, Ybx2 methylation maintains 
pericytes in a nonquiescent phenotype with a higher potential 
for reactivation by further injuries and to promote indolent 
CKD progression.
Figure 1. Acute kidney injury induced a transient increase in renal myofibroblasts. (A) Representative images showing Col1a1-GFP+α-smooth mus-
cle actin (αSMA)+ myofibroblasts in the kidneys of Col1a1-GFPTg mice before (Ctrl) injury and at the indicated time points (day 2–56) after acute kidney 
injury (AKI) induced by right nephrectomy (Nx) followed by left ischemia/reperfusion injury (IRI). Arrows, arrowheads, and asterisks indicate Col1a1-GFP+ 
pericytes, Col1a1-GFP+αSMA+ myofibroblasts, and Col1a1-GFP–αSMA+ vascular smooth muscle cells, respectively. Scale bar: 25 μm. Original magnification, 
×400. (B) Dot chart showing the cell numbers of Col1a1-GFP+αSMA+ myofibroblasts per high-powered field (HPF) at ×400 at the indicated time points.  
(C) Dot chart showing the proportion of αSMA+Col1a1-GFP+ myofibroblasts to Col1a1-GFP+ pericytes. Horizontal bars represent the mean, error bars repre-
sent the SEM. **P < 0.01, ***P < 0.001 vs. Ctrl by 1-way ANOVA with post hoc Dunnett’s correction. n = 5.
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Figure 2. Renal myofibroblasts were derived from pericytes during acute kidney injury. (A) Experimental scheme showing cohort labeling by tamoxifen 
and AKI-induced by Nx + IRI (IRI-AKI) in Col1a2-CreERTTg ROSA26fstdTomato/+ mice. Analyses were performed at the indicated time points. (B) Representative 
images showing the Col1a2-RFP+ pericyte lineage and αSMA+Col1a2-RFP+ myofibroblasts in the kidneys. Arrows and arrowheads indicate Col1a2-RFP+ 
pericytes and αSMA+Col1a2-RFP+ myofibroblasts, respectively. Scale bars: 25 μm. Original magnification, ×400. (C) Dot chart showing the cell numbers of 
the Col1a2-RFP+ pericyte lineage/HPF at the indicated time points. (D) Dot chart showing the cell numbers of αSMA+Col1a2-RFP+ myofibroblasts/HPF. (E) 
Dot chart showing the proportion of αSMA+Col1a2-RFP+ myofibroblasts to Col1a2-RFP+ pericytes. (F) AKI induced the activation of qPericytes into aPeri-
cytes. Based on the fate of Col1a2-RFP+ pericytes (Supplemental Figures 4–6), aPericytes might undergo apoptosis or inactivation (iPericytes) by day 28 
after IRI-AKI. Horizontal bars represent the mean, error bars represent the SEM. *P < 0.05, **P < 0.01, ***P < 0.001 vs. Ctrl by 1-way ANOVA with post hoc 
Dunnett’s correction. n = 5.
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Col1a2-RFP+ pericytes were detected soon after IRI-AKI (Supple-
mental Figures 4–6). In agreement with the finding from TUNEL 
staining, we also detected apoptotic pericytes by the colocaliza-
tion of cleaved caspase-3 and Col1a2-RFP (Supplemental Figure 
7). TUNEL+Col1a2-RFP+ pericytes predominated after day 7 of 
IRI-AKI, suggesting that myofibroblasts underwent apoptosis and 
the cell numbers decreased during renal recovery (Supplemental 
Figure 6). It was noteworthy that cell numbers of Col1a2-RFP+ 
pericytes and αSMA+Col1a2-RFP+ myofibroblasts did not return to 
the numbers found in the Ctrl kidneys and increased after day 56 
(Figure 2, B–D). Though the cell numbers of αSMA+Col1a2-RFP+ 
myofibroblasts continued to be higher than those in the Ctrl kid-
neys, the proportion of αSMA+Col1a2-RFP+ myofibroblasts to 
Col1a2-RFP+ pericytes decreased significantly from day 28 (Figure 
2, B, D, and E), corresponding to the suggestion above that activat-
ed pericytes/myofibroblasts underwent inactivation during renal 
recovery (Figure 1, A and C).
Myofibroblasts underwent inactivation during renal recovery 
from AKI. To study the role of pericytes in the AKI-CKD contin-
uum, we performed a whole-genome microarray of kidney peri-
cytes isolated from different time points before and after IRI-AKI. 
Heatmap and principal component analysis (PCA) demonstrated 
distinctive gene expression patterns of pericytes isolated from the 
indicated time points (Supplemental Figure 8). Hence, we defined 
the pericytes isolated from different time points as being in the 
quiescent (qPericytes, normal kidney), activated (aPericytes or 
myofibroblasts, AKI on day 7), and inactivated (iPericytes, AKD 
on day 28) status, respectively. According to the cell numbers of 
Col1a2-RFP+ pericytes in Figure 2C, the fate of aPericytes includ-
tubular epithelial cells enclosed by laminin+ basement membrane, 
CD31+ endothelial cells, and F4/80+ macrophages did not coex-
press Col1a1-GFP or αSMA (Supplemental Figure 2). In parallel 
with the transient increase in the number of αSMA+Col1a1-GFP+ 
myofibroblasts, the proportion of αSMA+Col1a1-GFP+ myofibro-
blasts to Col1a1-GFP+ pericytes also decreased markedly from 
day 28 (Figure 1, A and C), suggesting that the activated pericytes/
myofibroblasts underwent inactivation during renal recovery.
Although more than 80% of Col1a1-GFP+ pericytes coex-
pressed the myofibroblast marker αSMA from day 2 to day 14 after 
IRI-AKI (Figure 1, A and C), Col1a1-GFP was a dynamic marker 
whose detection relied on the active expression of the Col1a1 gene 
(15). To unbiasedly determine the contribution of pericytes to myo-
fibroblasts and their fate after AKI, we generated Col1a2-CreERTTg 
ROSA26fstdTomato/+ mice and permanently labeled Col1a2-express-
ing pericytes with red fluorescence protein (RFP) by tamoxi-
fen. Although only 60% of Col1a1-GFP+ pericytes coexpressed 
Col1a2-RFP, all Col1a2-RFP+ cells were Col1a1-GFP+ pericytes 
in Col1a1-GFPTg Col1a2-CreERTTg ROSA26fstdTomato/+ mice (Supple-
mental Figure 3, A–C) and we could trace the fate of genetically 
labeled Col1a2-RFP+ pericytes after AKI in the following experi-
ments. Similar to the findings in Col1a1-GFPTg mice (Figure 1), the 
cell numbers of Col1a2-RFP+ pericytes and αSMA+Col1a2-RFP+ 
myofibroblasts in the kidneys of Col1a2-CreERTTg ROSA26fstdTomato/+ 
mice increased after IRI-AKI and more than 80% of Col1a2-RFP+ 
pericytes coexpressed αSMA from day 2 to day 14 (Figure 2, A–E). 
According to the staining of terminal deoxynucleotidyl transfer-
ase dUTP nick end labeling (TUNEL) and Ki67 in kidneys before 
(Ctrl) and after IRI-AKI, both cell apoptosis and proliferation of 
Figure 3. Inactivated pericytes retained a higher potential for fibrosis and cell proliferation in vitro. (A) Primary cultures of qPericytes and iPericytes 
from the kidneys before and on day 28 after IRI-AKI, respectively, were exposed to TGF-β1 or Ctrl culture medium for 16 hours. Dot charts showed the 
expression of Acta2, Col1a1, and Timp1 assessed by quantitative PCR. The expression levels were normalized by Gapdh. Horizontal bars represent the 
mean, error bars represent the SEM. *P < 0.05, **P < 0.01 by 1-way ANOVA with post hoc Tukey’s correction. n = 4 for each group. (B) Line chart show-
ing the cell proliferation of qPericytes and iPericytes assessed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Data are 
expressed as the mean ± SEM. *P < 0.05 by t test at each time point. n = 4 for each group.
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3B). One month after the first IRI-AKI, mice showed higher BUN 
and creatinine and more myofibroblasts when they were subject-
ed to a second AKI induced by adenine (adenine-AKI) (Figure 
4, A–D). Increased cell proliferation was demonstrated in renal 
αSMA+ myofibroblasts of mice subjected to adenine-AKI 1 month 
after functional recovery from IRI-AKI (Figure 4, E and F). Togeth-
er, these data demonstrated that renal iPericytes retained a higher 
potential for reactivation, signifying their profibrotic role in func-
tionally recovered kidneys subjected to a second AKI.
Demethylation by 5-azacytidine during AKI attenuated CKD 
progression after renal recovery. Because iPericytes have a higher 
potential for reactivation than qPericytes, epigenetic modification 
was studied. We found increased expression of DNA methyltrans-
ferase 1 (DNMT1) in Col1a2-RFP+ aPericytes (Supplemental Fig-
ure 10A) and upregulation of renal DNMT1 protein after IRI-AKI 
(Supplemental Figure 10, B and C). In addition, the expression 
levels of renal Dnmt1, Dnmt3a, and Dnmt3b were upregulated 
ed apoptosis (79.1%) and inactivation (20.9%) during renal recov-
ery from AKI (Figure 2F). We also found that renal expression of 
platelet-derived growth factor-B and transforming growth fac-
tor-β1 (TGF-β1), 2 key growth factors for pericyte proliferation 
and activation (7, 16), were transiently increased, providing a 
possible explanation for the change in pericyte number after AKI 
(Supplemental Figure 9).
iPericytes retained a higher potential for reactivation by inju-
ries. We cultured qPericytes and iPericytes isolated from normal 
and day 28 AKD kidneys, respectively. Though the proportion 
of αSMA+Col1a2-RFP+ aPericytes to all Col1a2-RFP+ pericytes 
decreased significantly from day 28 after AKI (Figure 2, B and E), 
the expression levels of Acta2 in iPericytes were higher than those 
in qPericytes (Figure 3A). In addition, iPericytes showed a higher 
profibrotic potential as evidenced by elevated expression levels of 
Acta2, Col1a1, and Timp1 induced by TGF-β1 (Figure 3A). More-
over, iPericytes showed a higher proliferative potential (Figure 
Figure 4. Inactivated pericytes retained 
a higher potential for cell proliferation 
induced by a second injury in vivo. (A) 
Experimental scheme of a second AKI on 
the kidneys that recovered from the first 
AKI. IRI-AKI was induced on day 0 and 
allowed to recover until the second AKI 
induced by 1-week adenine diet from day 
28. Sham operation on day 0 and regular 
diet from day 28 served as the Ctrl. The 
mice were allocated to group 1 (IRI+adenine, 
AKI on kidneys that recovered from the first 
AKI), group 2 (adenine, single AKI), group 3 
(IRI, single AKI), and group 4 (Nx only, Ctrl). 
(B) Dot charts showing the plasma levels 
of BUN and Cre. (C) Representative images 
showing αSMA+ myofibroblasts in the kid-
neys. Scale bars: 25 μm. Original magnifi-
cation, ×400. (D) Dot chart showing the cell 
numbers of αSMA+ myofibroblasts/HPF at 
×400 in the renal sections. (E) Representa-
tive images showing Ki67+αSMA+  
myofibroblasts in the kidneys. Scale bars: 
25 μm. Original magnification, ×400. (F) 
Dot chart showing the cell numbers of 
Ki67+αSMA+ myofibroblasts/HPF in the 
renal sections. Horizontal bars represent 
the mean, error bars represent the SEM.  
*P < 0.05, **P < 0.01, ***P < 0.001 by 1-way 
ANOVA with post hoc Tukey’s correction.  
n = 5 for each group.
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after injury (Supplemental Figure 10D). To gain insight into the 
role of DNA methylation in the AKI-CKD transition, mice were 
administered with 5-Aza or vehicle for 2 weeks after IRI or sham 
operation and analyzed on day 28 and day 180 (Figure 5A). The 
levels of BUN and creatinine were similar between the groups on 
day 28, but both increased significantly in mice on day 180 after 
IRI-AKI (Figure 5B). AKI mice treated with 5-Aza showed lower 
increases in BUN and creatinine on day 180 (Figure 5B). Patho-
logic study revealed increased Picrosirius red–stained fibrotic area 
and αSMA+ myofibroblasts in kidneys after IRI-AKI, both attenu-
ated by 5-Aza treatment (Figure 5, C–E). The reduction of renal 
Acta2 expression further confirmed the preventive effect of 5-Aza 
treatment (Figure 5F). These data suggested the impact of epigen-
etic modification by methylation during AKI on the subsequent 
development of CKD.
5-azacytidine reversed aPericytes to become quiescent. To study 
how the changes in DNA methylation during AKI affects the 
response of recovered kidneys to a second AKI, we treated mice 
with 5-Aza or vehicle after IRI-AKI and then induced the second 
AKI by adenine on day 28 (Figure 6A). Nx only and regular diet 
served as the Ctrl. The plasma levels of BUN and creatinine were 
higher in the repeated AKI group (IRI+adenine) than those of the 
single AKI group induced by either IRI or adenine (Figure 6, B and 
C). No difference in BUN and creatinine was found between the 
IRI-AKI and Ctrl groups, demonstrating functional recovery from 
the first IRI-AKI (Figure 6, B and C). Compared with the repeat-
ed AKI group treated by vehicle, the group with 5-Aza treatment 
showed fewer αSMA+ myofibroblasts and Ki67+αSMA+ myofibro-
blasts, less Picrosirius red–stained fibrotic area, and lower profi-
brotic gene expression, but had no change on the levels of BUN 
and creatinine induced by the second adenine-AKI (Figure 6, B–J). 
These data showed that demethylation during AKI could atten-
uate the profibrotic response but did not affect the functional 
abnormality induced by repeated or a second AKI.
We cultured aPericytes from kidneys on day 7 after AKI and 
stimulated them with TGF-β1 after 3-day exposure to 5-Aza or 
vehicle (Supplemental Figure 11A). qPericytes isolated from nor-
mal kidneys served as Ctrl. After 5-Aza treatment, the baseline 
expression of Acta2 in aPericytes was reduced to the level shown in 
qPericytes, the upregulation of Acta2 by TGF-β1 was also reduced 
(Supplemental Figure 11B). The levels of baseline and TGF-β1–
induced expression of Col1a1 in aPericytes were also reduced after 
5-Aza treatment (Supplemental Figure 11C).
Since 5-Aza could decrease the expression of the activa-
tion marker Acta2 in aPericytes, we then studied whether 5-Aza 
could affect the function of aPericytes for vascular stabilization 
in 3D collagen gels (Figure 7A). Capillary network formation was 
demonstrated 24 hours after coculture of pericytes and human 
umbilical vein endothelial cells (HUVECs) in the collagen gel 
(Figure 7, B and C). At baseline, the capillary density was lower in 
HUVECs alone and coculture with aPericytes (Figure 7D). Cocul-
ture with qPericytes but not aPericytes could retard kallikrein- 
induced capillary tube regression and gel retraction (Figure 7, E 
and F). However, aPericytes after 5-Aza treatment resumed their 
function for vascular stabilization (Figure 7, E and F). qPericytes 
expressed higher levels of microvascular stabilizing and angio-
genic factors including Timp3, Angpt1, and Angpt2, which encoded 
tissue inhibitor of metalloproteinase-3 (TIMP3), angiopoietin-1, 
and angiopoietin-2, respectively (Figure 7G). Treatment with 
5-Aza reversed the repression of these vascular stabilizing factors 
in aPericytes, a mechanism supporting the recovery of function for 
vascular stabilization. These data collectively demonstrated that 
demethylation by 5-Aza could reverse aPericytes to become more 
similar to qPericytes.
Ybx2 and Acta2 showed the opposite expression patterns in peri-
cytes after AKI. In our whole-mouse genome microarray, we 
identified substantial changes in the expression of 246 genes 
in pericytes after AKI. Among these genes, we focused on Ybx2 
Figure 5. Demethylation by 5-azacytidine during acute kidney injury 
attenuated the progression to chronic kidney disease. (A) Experimental 
scheme for the IRI-AKI and 5-azacytidine (Aza) treatment. Nx followed 
by sham operation served as the Ctrl. Plasma BUN and Cre were analyzed 
on day 28 and day 180. Kidneys were analyzed on day 180. (B) Dot charts 
showing the plasma BUN and Cre in each group. (C) Representative images 
showing Picrosirius red staining in the renal sections on day 180. Scale 
bars: 50 μm. (D) Dot chart showing the quantification of Picrosirius red–
stained fibrotic area in the renal sections. (E) Dot chart showing the cell 
numbers of αSMA+ myofibroblasts/HPF in the renal sections. (F) Dot chart 
showing the renal Acta2 expression normalized by Gapdh. Horizontal bars 
represent the mean, error bars represent the SEM. *P < 0.05, ***P < 0.001 
by 1-way ANOVA with post hoc Tukey’s correction. n = 5 for each group.
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because it was a plausible repressor of Acta2 in qPericytes. YBX2 
could be identified in the Ctrl kidneys by immunohistochemistry, 
especially in interstitial cells (Figure 8A and Supplemental Figure 
12A). Col1a1-GFP+ pericytes expressed YBX2 in the Ctrl kidneys 
of Col1a1-GFPTg mice (Figure 8B and Supplemental Figure 12B). 
Interestingly, YBX2 staining increased in injured tubular epithelial 
cells after IRI-AKI but decreased in interstitial cells (Figure 8C and 
Supplemental Figure 12A). The renal expression of Ybx2 mRNA 
Figure 6. Demethylation by 5-azacytidine during acute kidney injury attenuated the reactivation of pericytes and renal fibrosis induced by a second 
injury. (A) Experimental scheme of adenine-AKI on the kidneys that recovered from the first IRI-AKI. The protocol for the administration of Aza or vehicle 
is shown in Figure 5A. Sham operation on day 0 and regular diet from day 28 served as the Ctrl. The mice were allocated to group 1 (IRI + adenine), group 
2 (adenine only), group 3 (IRI only), group 4 (IRI + Aza + adenine), and group 5 (Nx only, Ctrl). Analyses were performed on day 35. (B) Dot charts showing 
the plasma BUN and Cre. n = 5. (C) Representative images showing αSMA+ myofibroblasts in the renal sections. Scale bars: 25 μm. Original magnification, 
×400. n = 5. (D) Representative images showing Ki67+αSMA+ myofibroblasts in the kidneys. Scale bars: 25 μm. Original magnification, ×400. n = 5. (E) Dot 
chart showing the cell numbers of αSMA+ myofibroblasts/HPF in the renal sections. n = 5. (F) Dot chart showing the cell numbers of Ki67+αSMA+ myofi-
broblasts in the renal sections. n = 5. (G) Dot chart showing the quantification of Picrosirius red–stained fibrotic area in the renal sections. n = 5. (H–J) Dot 
chart showing the expression of renal Acta2, Col1a1, and Col3a1. Horizontal bars represent the mean, error bars represent the SEM. *P < 0.05, **P < 0.01, 
***P < 0.001 by 1-way ANOVA with post hoc Tukey’s correction. n = 4 for each group.
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and Ybx2 in aPericytes was reduced after 5-Aza treatment (Supple-
mental Figure 13). Consistently, the expression levels of Ybx1, Ybx2, 
Tead1, and Pura mRNAs were higher in qPericytes than those in 
aPericytes (Supplemental Figure 15). Demethylation by 5-Aza par-
tially recovered the expression of these genes in aPericytes.
We then designed 3 pairs of primers to amplify different pro-
moter regions of the Acta2 gene (Figure 9C). By chromatin immu-
noprecipitation-polymerase chain reaction (ChIP-PCR), we identi-
fied that the promoter regions of Acta2 were bound by YBX2 protein 
(Figure 9D). In addition to suppressing Ybx2 transcription (Figure 
9A), TGF-β1 exposure also decreased the binding of YBX2 to the 
Acta2 promoter (Figure 9D). We then demonstrated that lentiviral 
overexpression of YBX2 decreased αSMA expression in aPericytes 
(Figure 9, E and F). These data collectively demonstrated that Ybx2 
methylation in pericytes led to a higher potential for reactivation.
Discussion
We report 4 important findings in the fate and role of pericytes 
after AKI: (a) pericytes are the major progenitor cells of renal 
was not different between Ctrl and IRI-AKI (Figure 8D), but quan-
titative PCR showed that Ybx2 mRNA decreased in aPericytes on 
day 7 after IRI-AKI and recovered partially in iPericytes on day 
28 (Figure 8E). In contrast, Acta2 mRNA in pericytes showed the 
opposite trend (Figure 8F).
The promoter of the Acta2 repressor Ybx2 was methylated in peri-
cytes after AKI. TGF-β1 exposure decreased Ybx2 mRNA in the 
primary culture of qPericytes (Figure 9A). The expression of Ybx2 
bounced back upon the removal of TGF-β1 after 24-hour exposure; 
however, the expression of Ybx2 did not return upon the removal of 
TGF-β1 after 5-day exposure (Figure 9A). Methylated DNA immu-
noprecipitation (MeDIP) revealed the methylation of Ybx2 promot-
er in qPericytes after exposure to TGF-β1 for 5 days (Figure 9B). In 
aPericytes isolated from kidneys on day 7 after IRI-AKI, MeDIP con-
firmed the methylation of Ybx2 (Supplemental Figure 13). Bisulfite 
genomic sequencing confirmed the hypermethylation of the Ybx2 
promoter in aPericytes (Supplemental Figure 14). Moreover, we 
also demonstrated the methylation of Tead1, Pura, and Ybx1, known 
Acta2 repressors (29–32). The methylation of Tead1, Pura, Ybx1, 
Figure 7. Demethylation by 5-azacyti-
dine reversed the vascular stabilizing 
function of myofibroblasts. (A) The 
scheme showing the model of 3D 
capillary formation by mixing pericytes 
(green) and HUVECs (red) in collagen 
gels. (B) A representative bright-field 
image demonstrating the cross sections 
of capillary tubes 24 hours after mixing 
pericytes and HUVECs in collagen gels. 
Scale bars: 250 µm. Original magnifica-
tion, ×4. (C) A representative immuno-
fluorescent image showing capillary for-
mation (red) 24 hours after mixing the 
pericytes and CellTracker Red–stained 
HUVECs in collagen gels. Scale bars: 
250 µm. Original magnification, ×4. (D) 
Dot chart showing the vascular density 
in the collagen gels in the presence of 
coculture with qPericytes (qPC), aPeri-
cytes (aPC, myofibroblasts), aPericytes 
after Aza treatment for 3 days (aPC 
+ Aza), or in the absence of pericyte 
coculture (HUVEC alone) for 24 hours. n 
= 10. (E) Images showing the collapse of 
collagen gels induced by kallikrein (KLK) 
in gels with HUVECs in the presence 
or absence of pericyte coculture. Scale 
bars: 250 μm. Original magnification, 
×4. (F) Line chart showing the per-
centage of collapsed area in gels with 
HUVECs in the presence or absence of 
pericyte coculture at the indicated time 
points after KLK administration. n = 10. 
(G) Dot charts showing the expression of 
Timp3, Angpt1, and Angpt2 assessed by 
quantitative PCR. The expression levels 
were normalized to Gapdh. Horizontal 
bars represent the mean, error bars 
represent the SEM. n = 4. *P < 0.05, **P 
< 0.01, ***P < 0.001 by 1-way ANOVA 
with post hoc Tukey’s correction.
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show a phenotype distinct from qPericytes. Mechanistic studies 
demonstrated that iPericytes retained a higher potential for cell 
proliferation, ECM production, and reactivation to aPericytes in 
response to injuries again.
We discovered the distinct populations of qPericytes, aPeri-
cytes (myofibroblasts), and iPericytes in kidneys before (normal 
control), on day 7 (AKI), and on day 28 (AKD) after AKI using a 
whole-mouse genome microarray. Because the potential of iPeri-
cytes for cell proliferation and ECM production was higher than 
that of qPericytes, and the expression of Acta2 in iPericytes was 
lower than that in aPericytes, our study further focused on the 
mechanisms underlying the change in activation status and func-
tion of these distinct pericyte populations. The epigenetic modifi-
cations in CKD myofibroblasts have been well studied, such as the 
hypermethylation of Rasal1, Epo, and Hif2a (8, 17, 34). Burgeoning 
studies have also shown that epigenetic processes are involved in 
the pathogenesis of AKI (35). Because αSMA is a robust activation 
marker for aPericytes (18), we studied the epigenetic regulation 
of Acta2, the expression of which is known to be transcriptional-
ly upregulated by TGF-β1 (7, 36). Here, we identified that genes 
encoding Acta2 repressors, including Ybx2, Ybx1, Tead1, and Pura, 
were hypermethylated in aPericytes. Prolonged exposure to TGF-1 
induced hypermethylation of the Ybx2 promoter, thereby decreas-
ing Ybx2 expression. In aPericytes after treatment with demeth-
ylating agent 5-Aza, the expression of Ybx2, Timp3, Angpt1, and 
Angpt2 increased, the expression of Acta2 decreased, and the 
function for microvascular stabilization recovered.
In addition to the aforementioned evidence in pericyte cul-
tures, we further demonstrated that 5-Aza treatment during AKI at 
a clinically relevant and nontoxic dose could reduce not only the 
accumulation of αSMA+ myofibroblasts and renal fibrosis but also 
the elevation of BUN and creatinine in mice on day 180 after AKI, 
showing the effect of demethylation on the prevention of AKI-CKD 
transition. In mice treated with 5-Aza after the first AKI, the prolif-
eration and cell numbers of αSMA+ aPericytes and renal fibrosis in 
myofibroblasts after AKI through the activation of αSMA and cell 
proliferation; (b) apoptosis lowers the number of myofibroblasts 
during renal recovery, but the cell number and activation potential 
do not return to the quiescent baseline due to hypermethylation 
of Acta2 repressor genes such as Ybx2; (c) Ybx2 hypermethylation 
maintains pericytes in an inactivated, nonquiescent phenotype, 
which is prone to reactivation upon a second AKI; (d) demethyl-
ation by 5-Aza switches myofibroblasts back to a quiescent status 
with the function of vascular stabilization.
Kidney pericytes are named when they are embedded within 
the microvascular basement membrane and in close contact with 
endothelial cells (15, 22, 24). When these cells are not in direct 
contact with endothelial cells, they are called perivascular fibro-
blasts (15). Pericytes have been demonstrated as the major source 
of scar-producing myofibroblasts in CKD with progressive fibrosis 
(15, 22, 24). Primary myofibroblasts isolated from fibrotic kidneys 
remain activated even when cultured in vitro (33). In line with our 
findings in AKI, hypermethylation of the Rasal1 gene leads to the 
perpetuation of myofibroblast activation and fibrogenesis in CKD 
(8). However, hypermethylation of the Epo gene in myofibroblasts 
leads to decreased EPO production and CKD anemia (17). In con-
trast with the profibrotic effect of myofibroblasts in CKD (15, 22, 
24), AKI myofibroblasts are activated transiently to enclose the 
injured tubular epithelium and promote tubular regeneration (26). 
Although further studies are needed to delineate the prorepara-
tive effect of AKI myofibroblasts, our findings emphasize the role 
of myofibroblasts in AKI-CKD transition due to the decrease of 
Acta2 repressors by hypermethylation during AKI.
By mapping the fate of Col1a2-RFP+ pericytes, we found that 
up to one-fifth of pericytes activated by AKI escaped apoptosis 
and became inactivated during recovery. In addition, our results 
showed that cell numbers of iPericytes did not return to the base-
line level before AKI. Moreover, the cell numbers of iPericytes 
increased again with progressive renal fibrosis and function 
decline during follow-up. These findings suggested iPericytes 
Figure 8. YBX2 expression in pericytes decreased after acute kidney 
injury. (A) Representative images showing the immunohistochemistry 
staining of YBX2 in the Ctrl kidneys. Arrows indicate YBX2+ interstitial 
cells. Scale bars: 25 µm. Original magnification, ×400. (B) Represen-
tative images showing Col1a1-GFP+ qPericytes with YBX2 expression 
in the Ctrl kidney of Col1a1-GFPTg mice. Scale bars: 25 µm. Original 
magnification, ×400. (C) Representative images showing the immuno-
histochemistry staining of YBX2 in kidneys on day 7 after IRI-AKI. 
Arrowheads indicate YBX2+ tubular epithelial cells while asterisks 
indicate interstitial cells without YBX2. Scale bars: 25 μm. Original 
magnification, ×400. (D) Dot chart showing the expression of Ybx2 in 
the Ctrl and day 7 IRI-AKI kidneys. n = 5. (E and F) Dot chart showing 
the expression of Ybx2 and Acta2 in purified pericytes from the kidneys 
at the indicated time points after IRI-AKI. Horizontal bars represent the 
mean, error bars represent the SEM. n = 4. *P < 0.05, **P < 0.01, ***P < 
0.001 by 1-way ANOVA with post hoc Tukey’s correction.
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promoters of target genes and can also help stabilize mRNAs and 
regulate translation. YBX2 is highly expressed in germ cells and 
its deletion leads to infertility (38, 39). YBX2 expression and func-
tion in the kidney have not been shown before. Our data showed 
that Ybx2 expression was decreased in aPericytes and recovered 
partially in iPericytes, a pattern opposite of the change of Acta2 
expression. Mechanistically, we confirmed that YBX2 protein 
bound to the promoter region of Acta2 and YBX2 overexpression 
decreased αSMA expression, demonstrating YBX2 as a repressor 
of αSMA. Previous evidence has shown that the Acta2 promot-
er is bound by PURα, YBX1, and TEAD1 repressors in quiescent 
fibroblasts (29, 31, 40). In the presence of TGF-β1, conformation-
al changes occur and repressor proteins are removed from the 
promoter. TGF-β1 exposure for 1 day transiently decreased Ybx2 
mRNA in qPericytes. However, 5-day TGF-β1 exposure resulted 
in the methylation of the Ybx2 promoter, resulting in prolonged 
repression of Ybx2 mRNA even after TGF-β1 was withdrawn. In 
addition to Ybx2, we also showed methylation in the promoters of 
Tead1, Pura, and Ybx1 in aPericytes. Through the methylation of 
Acta2 repressor genes during AKI, iPericytes retained the epigene-
tic modification with a higher potential for reactivation by repeat-
ed injuries and may promote the transition toward CKD.
Why the expression of YBX2 increased in injured tubular 
epithelial cells after AKI is not clear and needs further study. 
Injured tubular epithelial cells may dedifferentiate after AKI, 
but they do not express αSMA and migrate through the base-
response to the second AKI were attenuated, showing the impact of 
methylation-induced epigenetic modification during the first AKI 
on cell proliferation and ECM production of iPericytes induced by 
a second AKI. All of these findings highlight that demethylation 
reduces aPericyte activation induced by AKI as well as reverses 
aPericytes to the phenotype of qPericytes, thereby preventing AKI-
CKD transition and reducing the impact of repeated AKI on AKD 
or subclinical CKD. It was noteworthy that 5-Aza treatment did 
not provide a discernible effect on the recovery of renal function 
on day 28 after IRI-AKI, suggesting that, during AKI, the impact of 
demethylation on the repair of the injured tubular epithelium was 
negligible. Although a previous report showed that selective tubu-
lar cell ablation causes transient activation and migration of peri-
cytes to enclose the injured tubular epithelium and promote tubu-
lar regeneration (26), 5-Aza treatment seemed not to change this 
function. Moreover, the finding of similar renal function impair-
ment induced by a second AKI in mice with or without 5-Aza treat-
ment emphasizes the negligible remote effect of demethylation on 
the response of kidneys to the second AKI. However, 5-Aza treat-
ment during AKI induces long-term protective effects against renal 
fibrosis and function impairment as observed on day 180 after AKI.
The dynamic interplay between the repressors and activators 
collaborates in the regulation of Acta2 gene expression in myofi-
broblasts (31). YBX2, known as a member of the Y-box family of 
DNA/RNA-binding proteins, functions as a transcriptional reg-
ulator in the nucleus (37). It can bind to a Y-box element in the 
Figure 9. YBX2 repressed the expression of 
Acta2. (A) Line chart showing the expression 
of Ybx2 mRNA in the primary kidney pericytes 
after TGF-β1 exposure and withdrawal at the 
indicated time points. Data were expressed as 
the mean ± SEM. n = 3. *P < 0.05 by t test vs. 
before TGF-β1 withdrawal. (B) Representative 
images showing the electrophoresis of the 
PCR products of the Ybx2 gene using MeDIP or 
input DNA from primary kidney pericytes after 
TGF-β1 exposure for 24 or 120 hours. Pericytes 
without TGF-β1 exposure served as the Ctrl. 
(C) Scheme showing the primer design in the 
promoter regions of the Acta2 gene. (D) Repre-
sentative images showing the electrophoresis 
of PCR products of the promoter of the Acta2 
gene using DNA immunoprecipitated by anti-
YBX2 antibody (ChIP) or input DNA from the 
primary kidney pericytes with or without TGF-β1 
exposure for 120 hours. ChIP using isotype IgG 
served as the Ctrl. (E) Representative Western 
blot analyses for YBX2, αSMA, and β-actin in 
pericytes with or without lentiviral transduction 
for YBX2 expression. (F) Dot chart showing 
the relative expression of YBX2 and αSMA in 
pericytes with or without lentiviral transduction 
for YBX2 expression. Horizontal bars represent 
the mean, error bars represent the SEM. n = 3. 
**P < 0.01, ***P < 0.001 by 1-way ANOVA with 
post hoc Tukey’s correction.
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Administration of 5-azacytidine to the mouse models of acute kid-
ney injury. Mice received 2 weeks of treatment by daily subcutaneous 
injections of either PBS vehicle or 5-Aza (0.5 mg/kg, MilliporeSigma) 
for 5 days per week after IRI as outlined in Figure 5A and Figure 6A.
Three-dimensional vascular tube regression assay. Isolated kidney 
pericytes from Col1a1-GFPTg mice and HUVECs (ScienCell Research 
Laboratories) were cocultured at a ratio of 1:8 in 3D vascular tube 
regression assays following a modified protocol as previously described 
(9). HUVECs (6 × 105 cells/mL) were suspended in 3 mg/mL rat tail 
collagen type I at 4°C (Invitrogen), transferred to a 37°C incubator, and 
were allowed to form 3D networks in the presence of vascular endo-
thelial growth factor 165 (40 ng/mL) and fibroblast growth factor 2 
(40 ng/mL) (PeproTech) in 384-well microplates (ibidi Inc.). Twenty- 
four hours later, human plasma kallikrein (KLK) (Enzyme Research 
Laboratories) was added to the cultures. Cultures were monitored for 
gel contraction and the gel-regressed area and vessel density were 
quantified at indicated time points by ImageJ 1.42 (NIH).
Magnetic methylated DNA immunoprecipitation (MeDIP). Genom-
ic DNA was extracted from cultured primary pericytes using the 
DNeasy Blood & Tissue Kit (QIAGEN). DNA was then sheared by son-
ication (Bioruptor Pico, Biosearch Technologies) to generate fragments 
between 100–600 bp. Using the MagMeDIP kit (Diagenode), the Mag-
bead-bound 5-methylcytosine antibody was used to immunoprecipitate 
methylated DNA. The beads were captured by a magnet to remove the 
supernatant. After washing, we resuspended the beads and eluted the 
immunoprecipitated DNA for PCR to detect the target DNA sequence.
Chromatin immunoprecipitation (ChIP). Using a ChIP kit (Magna 
ChIP A/G, MilliporeSigma), we cross-linked the protein-DNA com-
plexes by incubating pericytes with 1% formaldehyde. The reaction 
was stopped by adding glycine. The pericytes were harvested and son-
icated to shear the chromatin to an average length of about 1 kb. We 
then centrifuged the lysates for 10 minutes and collected the super-
natant. Both anti-YBX2 antibody (13538-1-AP, Proteintech) and mag-
netic beads were added in the supernatant and incubated overnight 
at 4°C. Then, the sample was loaded on a magnetic separator and the 
supernatant was removed completely. The magnetic bead–antibody/
chromatin complex was washed by resuspending the beads in cold 
buffers. We eluted and purified the DNA for PCR to detect the pres-
ence of the Ybx2 DNA sequence.
Lentiviral transduction. For the overexpression of YBX2, mYbx2 
(OriGene Technologies) was cloned into a Lentivector pCDH-CMV-
EF1-GFP+Puro. Lentivirus was generated by RNA Technology Plat-
form and Gene Manipulation Core, Academia Sinica. GFP virus 
(pAS7w.EGFP.puro) was used as the control. Pericytes were transduc-
ed by the virus to overexpress YBX2.
Bisulfite genomic sequencing (BGS). Genomic DNA was prepared 
from pericytes. Sodium bisulfite conversion of genomic DNA was 
performed using the EZ DNA Methylation Kit (ZYMO Research). 
The bisulfite-converted genomic DNA was used for PCR to amplify 
the promoter of Ybx2 using the primers shown in Supplemental Table 
2. The PCR products were then gel-purified with the QIAquick Gel 
Extraction Kit (QIAGEN). The eluted DNA fragments were ligated 
into the pGEM-T Easy Vector (Promega Corporation) and 4 colonies 
for each mouse were randomly chosen for sequencing.
Temporal induction of Cre recombinase activity by tamoxifen admin-
istration. Tamoxifen in olive oil (10 mg/mL) (MilliporeSigma) was 
prepared by sonication and was administered intraperitoneally into 
ment membrane to become myofibroblasts (22, 41). Increased 
Acta2 repressors including YBX2 might be one mechanism to 
maintain cells in the epithelial phenotype.
In conclusion, AKI activates qPericytes to aPericytes, namely 
myofibroblasts, of which one-fifth escape apoptosis and become 
nonquiescent iPericytes during renal recovery. These iPericytes 
retain methylation-induced repression of Acta2 repressors including 
Ybx2 and show a higher potential to promote AKI-CKD transition 
or fibrogenesis upon repeated AKI. Demethylation by 5-Aza during 
AKI/AKD may provide a strategy to prevent CKD development.
Methods
Animals. Col1a1-GFPTg transgenic reporter mice were generated in the 
C57BL/6 background as previously described (15). Col1a2-CreERTTg 
transgenic mice were generated using a 6-kb Col1a2 enhancer to 
induce the expression of a cDNA encoding the CreERT fusion protein 
(42). B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J reporter mice (referred 
to herein as ROSA26fstdTomato/+), B6 129S4-Foxd1tm1(GFP/cre)Amc/J (referred 
to herein as Foxd1Cre/+), and C57BL/6 WT mice were obtained from 
The Jackson Laboratory.
Mouse models of acute kidney injury. Adult (8–10 weeks) male mice 
were anesthetized with ketamine/xylazine (100/10 mg/kg, intraperi-
toneally) and subjected to right Nx. After 2 weeks, the left kidney was 
clamped for 22 minutes with a nontraumatic microaneurysm clip to 
induce IRI under the homeothermic blanket system (Stoelting Co.) to 
maintain the core body temperature at 37°C. Only the right Nx was 
performed in the Ctrl mice. Acute adenine nephropathy was induced 
in adult mice that were fed a pellet diet of LabDiet 5001 (TestDiet) 
containing 0.25% adenine (MilliporeSigma) for 5 days (43). Mice on a 
regular pellet diet of LabDiet 5001 served as Ctrl.
Isolation and culture of kidney pericytes. Pericytes were purified from 
kidneys using a previously described method (17). Briefly, the kidney was 
decapsulated, diced, and then incubated at 37°C for 40 minutes with 
collagenase (50 mg/μL, Roche Applied Science) and dispase (0.3 U/
μL, Roche Applied Science) in Hanks’ Balanced Salt Solution (Millipore-
Sigma). After centrifugation, cells were resuspended in 3 mL PBS/1% 
BSA and filtered (40 μm). For the transcriptome analysis, pericytes were 
isolated from the single-cell suspension by sorting GFP+RFP+F4/80-APC–
CD31-APC–CD324-APC– cells from Foxd1Cre/+ ROSA26fstdTomato/+ Col1a1-
GFPTg mice using a FACSAria cell sorter (BD Biosciences). Microarray 
data have been submitted to the MIAME compliant Gene Expression 
Omnibus (GEO) database (accession number GSE140988). In the rest 
of the experiments, pericytes were obtained by sorting GFP+ cells from 
Col1a1-GFPTg mice and cultured in DMEM with 10% FBS. Passage 0 cells 
were used for experiments. RNA and genomic DNA were extracted for 
experiments. In TGF-β1 exposure experiments, cells were washed with 1× 
PBS and supplied with culture medium with or without 5 ng/mL TGF-β1 
(R&D Systems) (Figure 3 and Figure 9). In aPericytes culture, cells were 
treated with 500 ng/mL 5-Aza (MilliporeSigma) or vehicle for 3 days, fol-
lowed by TGF-β1 treatment for 16 hours (Supplemental Figure 11). Cellu-
lar RNA was then extracted for experiments.
Cell proliferation assay. Cell proliferation was evaluated using a 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 
MilliporeSigma) assay. Pericytes were seeded into a 96-well micro-
plate at a density of 1 × 104 cells/well. The kinetics of cell proliferation 
in pericytes was detected on days 0, 3, 5, and 7. The optical density (OD) 
at the wavelength of 490 nm was used to evaluate cell proliferation.
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1-AP, Proteintech), αSMA (ab125057, Abcam), DNMT1 (5032, Cell 
Signaling Technology), and β-actin (4967, Cell Signaling Technology).
Statistics. Data were expressed as the mean ± standard error of the 
mean (SEM). One-way ANOVA with post hoc Tukey’s correction was 
used for the comparison between each group. One-way ANOVA with 
post hoc Dunnett’s correction was used for the comparison between 
the control group and each of the other groups. Two-tailed Student’s 
t test was used to compare 2 different groups. A P value less than 0.05 
was considered significant. Statistical analyses were carried out using 
the GraphPad Prism software.
Study approval. All of the animal experiments were executed 
under a protocol approved by the Institutional Animal Care and Use 
Committee of the National Taiwan University College of Medicine.
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Col1a2-CreERTTg mice at 1 mg daily for 5 days at the age of 8 to 9 weeks 
(44). After a 10-day washout period, mice were subjected to AKI.
Tissue preparation and histology. For immunofluorescence stain-
ing, mouse tissues were prepared and stained as previously described 
(17). Primary antibodies against the following proteins were used 
for immunolabeling in 5 μm-thick cryosections: αSMA-Cy3 (C6198, 
clone 1A4), αSMA-FITC (F3777, clone 1A4), laminin (MilliporeSigma), 
DNMT1 (5032, Cell Signaling Technology), cleaved caspase-3 
(9664, Cell Signaling Technology), CD31 (14-0311-82, Invitrogen), 
F4/80 (14-4801-82, Invitrogen), YBX2 (ab33164, Abcam), and Ki67 
(Ab15580, Abcam). Nonimmunized rabbit IgG (011-000-003, Jack-
son ImmunoResearch Laboratories) was used as a control for YBX2 
staining. Apoptosis staining was performed by TUNEL assay (G3250, 
Promega Corporation). Fluorescence-conjugated secondary anti-
body labeling (Jackson ImmunoResearch Laboratories), 4′,6-diamid-
ino-2-phenylindole (DAPI) staining, Vectashield mounting (Vector 
Laboratories), and image capture and processing were carried out 
as previously described (44). Conventional and confocal images 
were taken with a Zeiss Axio Imager A1 Microscope with AxioVision 
Software and a Zeiss Laser Scanning 880 Microscope with Zen 2011 
Software, respectively (Carl Zeiss). Quantification of specific cells in 
tissue sections was carried out as follows. In brief, the GFP+, RFP+, 
and DAPI+ cells were identified by green, red, and blue fluorescence, 
respectively. The αSMA+ cells were identified by the presence of Cy3 
or FITC fluorescence in greater than 75% of the cell area immediately 
surrounding the nuclei detected by DAPI. Specific cells were counted 
in 10 randomly selected cortical interstitial fields per mouse at ×400 
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